期刊文献+

子宫内膜异位症患者异位、在位子宫内膜组织中VEGF、sflt-1 mRNA表达变化 被引量:6

Expression of VEGF and sflt-1 in endometriosis patients' ectopic endometrial tissue and eutopic endometrial tissueSHI
下载PDF
导出
摘要 目的观察子宫内膜异位症患者异位、在位子宫内膜组织中VEGF、sflt-1 mRNA表达变化。方法收集46例子宫内膜异位症患者的异位子宫内膜组织46份为异位组,在位子宫内膜组织32份为在位组,另收集30例非子宫内膜异位症患者子宫内膜组织为对照组。采用实时荧光定量PCR法检测各组VEGF mRNA、sFlt-1 mRNA,采用比较阈值法(2-△△Ct法)计算VEGF mRNA、sflt-1 mRNA相对表达量。结果在位组VEGF mRNA表达量明显高于对照组和异位组(P均<0.05),对照组VEGFmRNA表达量高于异位组(P<0.01);在位组内膜VEGF活性指数高于异位组和对照组(P<0.05),异位组VEGF活性指数高于对照组,但差异无统计学意义;对照组内膜sflt-1mRNA表达量高于在位组和异位组(P<0.05),在位组sflt-1mRNA表达量高于异位组(P<0.05)。结论子宫内膜异位症患者异位、在位子宫内膜组织中VEGF、sflt-1 mRNA表达异常。sflt-1可能参与了子宫内膜异位症的发病过程。 Objective To explore the expression of vascular endothelial growth factor( VEGF) and vascular endotheli-al growth factor soluble receptor-1( sflt-1) in endometriosis patients'ectopic endometrial tissue and eutopic endometrial tis-sue.Methods Forty-six parts of ectopic endometrial tissue of ectopic group were collected in 46 patients with endometrio-sis, thirty-two parts of eutopic endometrial tissue were involved as eutopic group.Thirty parts of endometrial tissue in non-endometriosis patients were collected as control group.VEGF and sflt-1 Mrna were detected by Real-time quantitative PCR assay, the expression levels were calculated using the difference threshold algorithm.Result Expression of VEGF Mrna and VEGF activity index in eutopic group were higher than those of ectopic group and control group( all P〈0.05) . Expression of VEGF Mrna in control group was higher than ectopic group(P〈0.01).Expression of sflt-1 in control group was higher than eutopic group and ectopic group, which in eutopic group was higher than ectopic group(all P〈0.05). Conclusions There are changes with expression of VEGF and sflt-1 in endometriosis patients'ectopic endometrial tissue and eutopic endometrial tissue.sflt-1 may be related to the pathogenesis of endometriosis.
出处 《山东医药》 CAS 2014年第34期18-20,共3页 Shandong Medical Journal
基金 河北省科技计划项目(12277740)
关键词 子宫内膜异位症 血管生成 血管内皮生长因子 血管内皮生长因子可溶性受体 endometriosis angiogenesis vascular endothelial growth factor vascular endothelial growth factor soluble receptor
  • 相关文献

参考文献9

  • 1Robby SJ,Mutter G L,Prat J.Robby's pathology of the female reproductive tract[M].2nd ed.Churchill Livingstone:Elsevier,2009:515-542.
  • 2Coccia ME,Rizzello F,Palagiano A,et al.Long-term follow-up after laparoscopic treatment for recurrence of endometriotic lesions and pain[J].Eur J Obstet Gynecol Reprod Biol,2011,157(1):78-83.
  • 3Hayasaka S,Ugajin T,Fujii O,et al.Risk factors for recurrence and re-recurrence of ovarian endometriosis after laparoscopic excision[J].J Obstet Gynaecol Res,2011,37(6):581-585.
  • 4Andraweera PH,Dekker GA,Roberts CT,et al.The vascular endothelial growth family in adverse pregnancy out-comes[J].Hum Peport Update,2012,18(4):436-457.
  • 5Lockwood CJ.Mechanisms of normal and abnormal endometrial bleeding[J].Menopause,2011,18(4):408-411.
  • 6董倩,李佩玲,孙美玲,刘梅梅,邱晓红.VEGF及其受体KDR在子宫内膜异位症中的表达及意义[J].现代妇产科进展,2012,21(11):873-877. 被引量:3
  • 7Ikeda T,Sun L,Tsuruoka N,et al.Hypoxia down-regulates sFlt-1(sVEGFR-1)expression in human microvascular endothelial cells by amechanism involving mRNA alternative processing[J].Biochem J,2011,436(2):399-407.
  • 8Wu FT,Stefanini MO,Mac F,et al.A systems biology perspective on sVEGFR1:its biological function,pathogenic role and therapeutic use[J].Cell Mol Med,2010,14(3):528-552.
  • 9Hull ML,Charnock-Jones DS,Chan CL,et al.Antiangiogenic agents are effec-tive inhibitors of endometriosis[J].Clin Endocrinol Metab,2003,88(6):2889-2899.

二级参考文献13

  • 1王含必,郎景和,冷金花,朱兰,刘珠凤,孙大为.血管内皮细胞生长因子受体在子宫内膜异位症中表达的研究[J].中华医学杂志,2005,85(22):1555-1559. 被引量:7
  • 2Harper SJ, Bates DO. VEGF-A splicing:the key to anti-an- giogenic therapeutics? [ J ]. Nat Rev Cancer, 2008, 8 (11) :880-887.
  • 3ChoSH,Oh YJ,Nam A,et al. Evaluation of serum and u- rinary angiogenic tactors in patients with endometriosis [ J ]. Am J Reprod Immunol, 2007,58 ( 6 ) :497-504.
  • 4Oosterlyneck D, Meuleman C, Sobis H,et al. Angiogenic activity of peritoneal fluid from women with endometriosis [ J]. Fertil Steril, 1993,59(4) :778-782.
  • 5Rein "DT, Schmidt T, Bauersc'hmitz G,et al. Treatment of endometriosis with a VEGF-targeted conditionally replica- tire adenovirus [ J ]. Fertil Steril, 2010,93 ( 8 ) : 2687-2694.
  • 6Machado DE, Abrao MS, Berardo PT, et al. Vascular density and distribution of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 ( Flk-1 ) are significantly higher in patients with deeply infiltrating endometriosis af- fecting the rectum[ JJ. Fertil Steri1,2008,90( 1 ) :148-155.
  • 7Ren QZ, Qian ZH, Jia SH, et al. Vascular endothelial growth factor expression up-regulated by endometrial is- chemia in secretory phase plays an important role in en- dometriosis [ J ]. Fertil Steril, 2011,95 ( 8 ) : 2687-2689.
  • 8Novella-Maestre E, Carda C, Ruiz-Sauri A, et al. Identifica- tion and quantification of dopamine receptor 2 in human eu- topic and ectopic endometrium:a novel molecular target for endometriosis therapy[ J ]. Biol Reprod, 2010,83 ( 5 ) : 866- 873.
  • 9Gilabert-Estelles J, Ramon LA, Espana F,et al. Expression of angiogenic factors in endometriosis: relationship to fi- brinolytic and metalloproteinase systems [ J ]. Hum Re- prod, 2007,22 ( 8 ) : 2120 -2127.
  • 10Moberq C,Catalano RD,Charnock-Jones DS,et al. VEGF- A and serum withdrawal induced changes in the transcript profile in human endometrial endothelial cells[J]. Reprod Sci,2010,17 (6) :590-611.

共引文献2

同被引文献51

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部